Letter re: SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis

Detalles Bibliográficos
Autores principales: Baba, Atsunori, Tokunaga, Takuya, Sakasegawa, Koichi, Kanekura, Takuro, Tsubouchi, Hirohito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148959/
https://www.ncbi.nlm.nih.gov/pubmed/37130465
http://dx.doi.org/10.1016/j.ejca.2023.03.036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148959/
https://www.ncbi.nlm.nih.gov/pubmed/37130465
http://dx.doi.org/10.1016/j.ejca.2023.03.036

Ejemplares similares